Ethicon | Johnson & Johnson | consumer protection violation | 2023 | KY-AG | $9,900,000 |
UCB Inc. | UCB | off-label or unapproved promotion of medical products | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $9,893,322 |
Medicis Pharmaceutical Corporation | Bausch Health | off-label or unapproved promotion of medical products | 2007 | DOJ_CIVIL | $9,800,000 |
Schwarz Pharma Inc. | UCB | False Claims Act and related | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $9,756,164 |
DePuy Synthes, Inc. | Johnson & Johnson | False Claims Act and related | 2023 | DOJ_CIVIL | $9,750,000 |
Abbott Laboratories | AbbVie | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Amgen Inc. | Amgen | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Dey, Inc. | Viatris | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Fujisawa Healthcare, Inc. | Astellas Pharma | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Hoechst Marion Roussel | Sanofi | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Immunex Corporation | Amgen | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Pharmacia Corporation | Pfizer | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
ZLB Behring, L.L.C. | CSL Limited | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Roxanne Laboratories and Boehringer Ingelheim | Hikma Pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $9,500,000 |
Pfizer Inc. | Pfizer | drug or medical equipment safety violation | 2014 | NV-AG | $9,500,000 |
Novo Nordisk A/S | Novo Holdings A/S | Foreign Corrupt Practices Act | 2009 | SEC | $9,030,149 |
Novo Nordisk A/S | Novo Holdings A/S | kickbacks and bribery | 2009 | DOJ_CRIMINAL | $9,000,000 |
General Nutrition | Harbin Pharmaceutical Group | wage and hour violation | 2016 | private lawsuit-federal | $9,000,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2003 | TX-AG | $9,000,000 |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $9,000,000 |
UCB Chemicals Corporation | UCB | price-fixing or anti-competitive practices | 2001 | private lawsuit-federal | $9,000,000 |
Warner Chilcott Holdings Company | AbbVie | price-fixing or anti-competitive practices | 2008 | private lawsuit-federal | $9,000,000 |
Alpharma Inc. | Pfizer | False Claims Act and related | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $8,900,000 |
Taro Pharmaceuticals USA, Inc. | Sun Pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $8,750,000 |
Endo Pharmaceuticals | Endo International | Controlled Substances Act violation | 2020 | OK-AG | $8,750,000 |
Schering-Plough Corporation | Merck | benefit plan administrator violation | 2010 | private lawsuit-federal | $8,500,000 |
Roxane Laboratories, Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2009 | FL-AG | $8,500,000 |
Merck | Merck | drug or medical equipment safety violation | 2013 | PA-AG | $8,250,000 |
Daiichi Sankyo | Daiichi Sankyo | employment discrimination | 2016 | private lawsuit-federal | $8,200,000 |
Pfizer, Inc. and Pharmacia Corporation | Pfizer | False Claims Act and related | 2010 | HI-AG | $8,200,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $8,200,000 |
Novartis Corporation and Alcon Laboratories | Novartis | employment discrimination | 2016 | private lawsuit-federal | $8,000,000 |
Warner Chilcott | AbbVie | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $8,000,000 |
AstraZeneca LP | AstraZeneca | False Claims Act and related | 2015 | DOJ_CIVIL | $7,900,000 |
Akorn Operating Company LLC | Akorn Inc. | False Claims Act and related | 2022 | DOJ_CIVIL | $7,900,000 |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | False Claims Act and related | 2010 | WI-AG | $7,750,000 |
Eisai | Eisai | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $7,634,700 |
Galena Biopharma Inc. | SELLAS Life Sciences Group | False Claims Act and related | 2017 | USAO | $7,550,000 |
Cephalon Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2015 | DOJ_CIVIL | $7,500,000 |
Cephalon, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,500,000 |
Allergan Ltd. | AbbVie | off-label or unapproved promotion of medical products | 2022 | RI-AG | $7,500,000 |
Salix Pharmaceuticals Inc. | Bausch Health | kickbacks and bribery | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,470,000 |
Astellas Pharma US Inc. | Astellas Pharma | False Claims Act and related | 2014 | DOJ_CIVIL | $7,300,000 |
Amgen Inc. | Amgen | False Claims Act and related | 2009 | IL-AG | $7,200,000 |
Medicis Pharmaceutical | Bausch Health | employment discrimination | 2016 | private lawsuit-federal | $7,150,000 |
Forest Laboratories Inc. | AbbVie | False Claims Act and related | 2019 | IL-AG | $7,089,034 |
Aventis | Sanofi | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
Janssen Pharmaceutical Products, LP, Centocor, Inc., McNeil Pharmaceutical, Inc., Ortho Biotech Products, LP and Ortho-McNeil Pharmaceutical, Inc. | Johnson & Johnson | False Claims Act and related | 2012 | KY-AG | $7,000,000 |
Novartis | Novartis | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
Teva Pharmaceutical USA, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | MA-AG | $7,000,000 |
Avanir Pharmaceuticals | Otsuka Pharmaceutical | False Claims Act and related | 2019 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,000,000 |
Abbott Laboratories | AbbVie | False Claims Act and related | 2008 | PA-AG | $6,950,000 |
Johnson & Johnson Consumer Companies, Inc. | Johnson & Johnson | consumer protection violation | 2017 | private lawsuit-federal | $6,750,000 |
InterMune Inc. | Roche | off-label or unapproved promotion of medical products | 2006 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,700,000 |
Novartis Pharmaceuticals | Novartis | off-label or unapproved promotion of medical products | 2012 | TX-AG | $6,638,250 |
Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc. | Viatris | False Claims Act and related | 2011 | KY-AG | $6,500,000 |
Teva Pharmaceuticals USA, Inc. et al. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | HI-AG | $6,500,000 |
Johnson & Johnson | Johnson & Johnson | consumer protection violation | 2020 | private lawsuit-federal | $6,315,000 |
Novo Nordisk Inc | Novo Holdings A/S | False Claims Act and related | 2022 | USAO | $6,300,000 |
Abbott Laboratories | AbbVie | False Claims Act and related | 2013 | LA-AG | $6,200,000 |
Merck & Co. Inc. | Merck | employment discrimination | 2019 | private lawsuit-federal | $6,200,000 |
Cephalon, Inc. | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2008 | CT-AG | $6,150,000 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | drug or medical equipment safety violation | 2010 | USAO | $6,140,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,104,000 |
Merck and Company | Merck | environmental violation | 2008 | EPA | $6,075,000 |
Inspire Pharmaceuticals | Merck | off-label or unapproved promotion of medical products | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,000,000 |
Merck Sharp & Dohme Corp. | Merck | False Claims Act and related | 2012 | KY-AG | $6,000,000 |
Par Pharmaceutical | Endo International | False Claims Act and related | 2013 | LA-AG | $6,000,000 |
Pfizer | Pfizer | drug or medical equipment safety violation | 2003 | MULTI-AG | $6,000,000 |
General Nutrition Centers Inc. | Harbin Pharmaceutical Group | consumer protection violation | 2019 | private lawsuit-federal | $6,000,000 |
Inspire Pharmaceuticals Inc. | Merck | off-label or unapproved promotion of medical products | 2015 | USAO | $5,900,000 |
Barr Pharmaceuticals | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $5,900,000 |
Janssen Ortho LLC and Janssen Pharmaceuticals, Inc. | Johnson & Johnson | off-label or unapproved promotion of medical products | 2014 | MT-AG | $5,900,000 |
Takeda Chemical | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2000 | CA-AG | $5,850,550 |
Takeda Pharmaceuticals U.S.A. | Takeda Pharmaceutical | False Claims Act and related | 2019 | IL-AG | $5,833,333 |
ICN Pharmaceuticals, Inc. | Bausch Health | fraud | 2001 | USAO | $5,600,000 |
AstraZeneca PLC | AstraZeneca | kickbacks and bribery | 2016 | SEC | $5,522,000 |
AstraZeneca | AstraZeneca | off-label or unapproved promotion of medical products | 2013 | KY-AG | $5,500,000 |
UCB Holdings, Inc. | UCB | benefit plan administrator violation | 2017 | private lawsuit-federal | $5,500,000 |
Warner Chilcott Holdings | AbbVie | price-fixing or anti-competitive practices | 2007 | MULTI-AG | $5,500,000 |
Abbott Laboratories | Abbott Laboratories | False Claims Act and related | 2013 | DOJ_CIVIL | $5,475,000 |
IVAX Pharmaceuticals | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $5,400,000 |
Merck & Co. Inc. | Merck | consumer protection violation | 2009 | MULTI-AG | $5,400,000 |
AstraZeneca | AstraZeneca | consumer protection violation | 2010 | KY-AG | $5,391,000 |
TAP Pharmaceutical Products | Takeda Pharmaceutical | False Claims Act and related | 2011 | PA-AG | $5,240,797 |
Johnson & Johnson et al. | Johnson & Johnson | False Claims Act and related | 2010 | HI-AG | $5,200,000 |
MERCK SHARP & DOHME CORP | Merck | environmental violation | 2006 | PA-ENV | $5,033,000 |
Dr. Reddy's Laboratories Inc. | Dr. Reddy's Laboratories | drug or medical equipment safety violation | 2018 | DOJ_CIVIL | $5,000,000 |
Synthes USA | Johnson & Johnson | wage and hour violation | 2016 | private lawsuit-federal | $5,000,000 |
CIBA Vision | Novartis | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $5,000,000 |
Ranbaxy | Sun Pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
Schering-Plough | Merck | False Claims Act and related | 2012 | LA-AG | $5,000,000 |
Taro Pharmaceutical Industries | Sun Pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
Johnson & Johnson Consumer Companies, Inc. | Johnson & Johnson | consumer protection violation | 2017 | private lawsuit-federal | $5,000,000 |
Alere Inc. | Abbott Laboratories | False Claims Act and related | 2018 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,860,779 |
Allergan | AbbVie | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $4,800,000 |
Dey L.P. | Viatris | False Claims Act and related | 2008 | AL-AG | $4,750,000 |
Baxalta US Inc. | Takeda Pharmaceutical | wage and hour violation | 2019 | private lawsuit-state | $4,750,000 |
Eisai Inc. | Eisai | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,658,249 |